Literature DB >> 23043184

Interactions between CYP2E1 and CYP2B4: effects on affinity for NADPH-cytochrome P450 reductase and substrate metabolism.

Cesar Kenaan1, Erin V Shea, Hsia-lien Lin, Haoming Zhang, Matthew J Pratt-Hyatt, Paul F Hollenberg.   

Abstract

Studies in microsomal and reconstituted systems have shown that the presence of one cytochrome P450 isoform can significantly influence the catalytic activity of another isoform. In this study, we assessed whether CYP2E1 could influence the catalytic activity of CYP2B4 under steady-state turnover conditions. The results show that CYP2E1 inhibits CYP2B4-mediated metabolism of benzphetamine (BNZ) with a K(i) of 0.04 µM. However, CYP2B4 is not an inhibitor of CYP2E1-mediated p-nitrophenol hydroxylation. When these inhibition studies were performed with the artificial oxidant tert-butyl hydroperoxide, CYP2E1 did not significantly inhibit CYP2B4 activity. Determinations of the apparent K(M) and k(cat) of CYP2B4 for CPR in the presence of increasing concentrations of CYP2E1 revealed a mixed inhibition of CYP2B4 by CYP2E1. At low concentrations of CYP2E1, the apparent K(M) of CYP2B4 for CPR increased up to 23-fold with virtually no change in the k(cat) for the reaction, however, at higher concentrations of CYP2E1, the apparent K(M) of CYP2B4 for CPR decreased to levels similar to those observed in the absence of CYP2E1 and the k(cat) also decreased by 11-fold. Additionally, CYP2E1 increased the apparent K(M) of CYP2B4 for BNZ by 8-fold and the apparent K(M) did not decrease to its original value when saturating concentrations of CPR were used. While the individual apparent K(M) values of CYP2B4 and CYP2E1 for CPR are similar, the apparent K(M) of CYP2E1 for CPR in the presence of CYP2B4 decreased significantly, thus suggesting that CYP2B4 enhances the affinity of CYP2E1 for CPR and this may allow CYP2E1 to out-compete CYP2B4 for CPR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043184      PMCID: PMC3533429          DOI: 10.1124/dmd.112.046094

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  46 in total

1.  A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function.

Authors:  E E Scott; M Spatzenegger; J R Halpert
Journal:  Arch Biochem Biophys       Date:  2001-11-01       Impact factor: 4.013

2.  Studies on the association of cytochrome P-450 and NADPH-cytochrome c reductase during catalysis in a reconstituted hydroxylating system.

Authors:  G T Miwa; S B West; M T Huang; A Y Lu
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

3.  Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding.

Authors:  Chuanwu Xia; Djemel Hamdane; Anna L Shen; Vivian Choi; Charles B Kasper; Naw May Pearl; Haoming Zhang; Sang-Choul Im; Lucy Waskell; Jung-Ja P Kim
Journal:  J Biol Chem       Date:  2011-02-23       Impact factor: 5.157

4.  Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.

Authors:  Haoming Zhang; Chitra Sridar; Cesar Kenaan; Hemali Amunugama; David P Ballou; Paul F Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  2011-06-09       Impact factor: 4.030

Review 5.  Formation of P450 · P450 complexes and their effect on P450 function.

Authors:  James R Reed; Wayne L Backes
Journal:  Pharmacol Ther       Date:  2011-11-29       Impact factor: 12.310

6.  Organization of NADPH-cytochrome P450 reductase and CYP1A2 in the endoplasmic reticulum--microdomain localization affects monooxygenase function.

Authors:  Lauren Brignac-Huber; James R Reed; Wayne L Backes
Journal:  Mol Pharmacol       Date:  2010-12-14       Impact factor: 4.436

7.  Uncovering the role of hydrophobic residues in cytochrome P450-cytochrome P450 reductase interactions.

Authors:  Cesar Kenaan; Haoming Zhang; Erin V Shea; Paul F Hollenberg
Journal:  Biochemistry       Date:  2011-04-22       Impact factor: 3.162

8.  Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate.

Authors:  Matthew Pratt-Hyatt; Hsia-lien Lin; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2010-09-08       Impact factor: 3.922

9.  Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation.

Authors:  James R Reed; Marilyn Eyer; Wayne L Backes
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

10.  CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification.

Authors:  Y Hu; K Krausz; H V Gelboin; D Kupfer
Journal:  Xenobiotica       Date:  2004-02       Impact factor: 1.908

View more
  3 in total

Review 1.  The functional effects of physical interactions involving cytochromes P450: putative mechanisms of action and the extent of these effects in biological membranes.

Authors:  James R Reed; Wayne L Backes
Journal:  Drug Metab Rev       Date:  2016-08       Impact factor: 4.518

2.  Variability in Human In Vitro Enzyme Kinetics.

Authors:  Christopher R Gibson; Ying-Hong Wang; Ninad Varkhede; Bennett Ma
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Physical Studies of P450-P450 Interactions: Predicting Quaternary Structures of P450 Complexes in Membranes from Their X-ray Crystal Structures.

Authors:  James R Reed; Wayne L Backes
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.